Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Theratechnologies Inc T.TH

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  THERF

Theratechnologies Inc is a pharmaceutical company addressing unmet medical needs in metabolic disorders. EGRIFTA is its registered trademark in the USA and it is used to commercialize its first product using its internally developed compound, tesamorelin.
Price: $1.36 Volume: 109,750
Change: $-0.04 % Change: -2.86%
Day High/Low: 1.41/1.35 52 Week High/Low: 1.49/0.325
Last Traded: May 22, 2015 11:56 Transaction Volume: 900
Open: 1.39 Previous Close: 1.40
Bid: 1.36 Ask: 1.40
Bid Size: 100 Ask Size: 14700
Market Cap: 83.0m Shares Out: 61.0m
PE Ratio: N/A Dividend Yield: N/A

Opinion

Euro Pacific raises Theratechnologies (T.TH) target to $1

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   October 20, 2014
0 stars

Mystery Movers: Biomed shares surging, triple digit rises all over, executives baffled

When you're standing on a launchpad and a rocket is taking off, the best place to be is on the rocket.

Chris Parry   November 19, 2013
0 stars

Mystery Movers: Spectral Diagnostics jumps 22% as Canadian biotech goes viral

You're still looking for rocks in the ground? Get with the program: Biotech is booming.

Chris Parry   November 5, 2013
0 stars

Junior energy stock pops on shale oil license award

This as a small pharmaceutical stock dropped following a non-compliance notice Friday

Sean Mason   June 22, 2012
0 stars

Latest Bullboard Posts

  • RE:insider buying update #2

    0 stars

    The insiders have spoekn with a collective voice given the insider buying and the absence of selling.

    4 stars


  • insider buying update #2

    0 stars

    Paul Pommier, corporate director buys 50000.......Luc Tanguay, president and CEO buys 25000...........Jean-Denis Talon , corporate...

    3 stars


  • RE:Paul Pommier

    0 stars

    insiders are taking a nice stake

    3 stars


  • RE:RE:Paul Pommier

    0 stars

    I found the answer to my question The black out period starts the first day of the next quarter  ....so his purchase was made within the...

    2.5 stars


  • RE:Paul Pommier

    0 stars

    He bought one week before the end of the quarter... when is the  black out period for insiders?

    2.5 stars